CLINICAL_TRIALS
trial_result
· 2024-09-26
Clinical Trial Update: Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Children Aged 1-12 Years [Phase 3]
Summary
Phase 3 trial evaluating immunogenicity and safety of a live attenuated varicella vaccine in children aged 1-12 years has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Southeast University, China | Conditions: Chickenpox Vaccines | Phase 3 | Status: COMPLETED